Lukas Lacina

Dr. Lukas Lacina

Department of Dermatovenerology and Institute of Anatomy, 1st Faculty of Medicine, Institute of Anatomy, Charles University, Prague 2, Czech Republic and BIOCEV, Vestec, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Cell
Verified
Journal Article
Closed access
FZFranklin L. Zhong
Franklin L. Zhong
OMOns Mamaï
Ons Mamaï
LSLorenzo Sborgi
Lorenzo Sborgi
LBLobna Boussofara
Lobna Boussofara
RHRichard Hopkins
Richard Hopkins
BRBruno Reversade
Bruno Reversade

5 January 2015 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
OKOndrej Kodet
Ondrej Kodet
Lukas LacinaLukas Lacina
Lukas Lacina
EKEliška Krejčí
Eliška Krejčí
BDBarbora Dvorankova
Barbora Dvorankova
MGMiloš Grim
Miloš Grim
Karel SmetanaKarel Smetana
Karel Smetana
Nodular melanoma is one of the most life threatening tumors with still poor therapeutic outcome. Similarly to other tumors, permissive microenvironment is essential for melanoma progression. Features of this microenvironment are arising from molecular crosstalk between the melanoma cells (MC) and the surrounding cell populations in the context of skin tissue. Here, we study the effect of melanoma cells on human primary keratinocytes (HPK). Presence of MC is as an important modulator of the tumor microenvironment and we compare it to the effect of nonmalignant lowly differentiated cells also originating from neural crest (NCSC).

21 November 2022 in Cells
Verified
Journal Article
Open access
PDF file
MRMagdalena Rašková
Magdalena Rašková
Lukas LacinaLukas Lacina
Lukas Lacina
Zdenek KejikZdenek Kejik
Zdenek Kejik
AVAnna Venhauerová
Anna Venhauerová
MSMarkéta Skaličková
Markéta Skaličková
JBJan Brábek
Jan Brábek
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-κB) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.

12 October 2016 in Anticancer Research
Verified
Journal Article
Open access
PDF file
Karel SmetanaKarel Smetana
Karel Smetana
Lukas LacinaLukas Lacina
Lukas Lacina
PSPavol Szabo
Pavol Szabo
BDBarbora Dvorankova
Barbora Dvorankova
PBProkop Brož
Prokop Brož
ASAleksi Sedo
Aleksi Sedo
An ageing population is a typical feature of many developed countries across the world. Analyzed from a biomedical and philosophical point of view, this phenomenon is also a potential risk factor for social sustainability of communities. The association between ageing and cancer seems to be more than apparent. Therefore, the further increase of epidemic-like incidence of malignant tumors in a population can be expected in the near future. Elderly people usually suffer from age-dependent diseases, and such polymorbidity can seriously affect the treatment of malignant tumors. Such an impending situation may be associated with multiple medical, social and economic issues. This article summarizes data about the possible molecular mechanism influencing rapid spreading of tumors in the elderly population. Reduction of the activity of DNA repair machinery is a likely genetic cause. Besides this, even epigenetic mechanisms can influence this process. In this context, the role of cancer stroma in controlling multiple biological properties of tumors is a prospective target for translational research with potential therapeutic outcomes.

21 April 2016 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
NJNjainday Pulo Jobe
Njainday Pulo Jobe
DRDaniel Rosel
Daniel Rosel
BDBarbora Dvorankova
Barbora Dvorankova
OKOndrej Kodet
Ondrej Kodet
Lukas LacinaLukas Lacina
Lukas Lacina
JBJan Brábek
Jan Brábek